Gráfico del Precio de Acciones HIND
HIND Ganando
Vyome Holdings Inc
$2.1
-4.54%
$-0.1
Al cierre: May 07, 16:00:00 GMT-4
$2.08
-0.53%
$-0.01
Mercado Posterior: May 07, 20:00:00 GMT-4
Atrás
Vyome Holdings Inc (HIND) Ganando
Estadísticas clave
Cierre Anterior
$2.2
Precio de apertura
$2.19
Rango del día
$2.08 - $2.21
Rango de 52 semanas
$1.75 - $46.6
Volumen
6.1K
Volumen promedio
597.7K
Rendimiento de dividendos
--
EPS (TTM)
63.63
Cap. de mercado
$14.6M
¿Qué es HIND?
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 9 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
Características
© 2026 Edgen impulsado por